Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional Accepts healthy volunteers

Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks

ClinicalTrials.gov ID: NCT05119439

Public ClinicalTrials.gov record NCT05119439. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Outpatient Medical Abortion Regimen With Mifepristone and Two Doses of Misoprostol at 71-77 and 78-84 Days of Pregnancy

Study identification

NCT ID
NCT05119439
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Gynuity Health Projects
Other
Enrollment
23 participants

Conditions and interventions

Interventions

  • Mifepristone + 2 doses of misoprostol 800 mcg Drug

Drug

Eligibility (public fields only)

Age range
11 Years to 55 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 6, 2022
Primary completion
Jun 29, 2023
Completion
Jun 29, 2023
Last update posted
Jul 24, 2023

2022 – 2023

United States locations

U.S. sites
6
U.S. states
4
U.S. cities
6
Facility City State ZIP Site status
University of Hawaii Hilo Hawaii 96720
University of Hawaii Honolulu Hawaii 96822
Planned Parenthood North Central States Saint Paul Minnesota 55114
Philadelphia Women's Center Philadelphia Pennsylvania 19106
Planned Parenthood Great Northwest, Hawai'i, Alaska, Indiana, Kentucky Federal Way Washington 98003
Planned Parenthood Great Northwest, Hawai'i, Alaska, Indiana, Kentucky Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05119439, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 24, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05119439 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →